Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Zeron-Medina

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cold Spring Harbor Perspectives in Biology|May 11, 2010
Single-nucleotide polymorphisms in the p53 signaling pathwayLukasz F Grochola, Jorge Zeron-Medina, Sophie Mériaux, et al.
Seminars in Oncology|November 29, 2015
The Personalization of Therapy: Molecular Profiling Technologies and Their ApplicationJorge Zeron-Medina, Maria Ochoa de Olza, Irene Braña, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 6, 2009
Acute abdominal pain in patients with systemic lupus erythematosusOmar Vergara-Fernandez, Jorge Zeron-Medina, Carlos Mendez-Probst, et al.
Pancreas|July 12, 2017
Overexpression of Yes Associated Protein 1, an Independent Prognostic Marker in Patients With Pancreatic Ductal Adenocarcinoma, Correlated With Liver Metastasis and Poor PrognosisMaria Teresa Salcedo Allende, Jorge Zeron-Medina, Javier Hernandez, et al.
Journal of the National Cancer Institute|March 13, 2018
Activity of HSP90 Inhibiton in a Metastatic Lung Cancer Patient With a Germline BRCA1 MutationSusana Cedrés, Enriqueta Felip, Cristina Cruz, et al.
Cell|October 15, 2013
A polymorphic p53 response element in KIT ligand influences cancer risk and has undergone natural selectionJorge Zeron-Medina, Xuting Wang, Emmanouela Repapi, et al.
Cell Reports|August 19, 2014
A polymorphic enhancer near GREM1 influences bowel cancer risk through differential CDX2 and TCF7L2 bindingAnnabelle Lewis, Luke Freeman-Mills, Elisa de la Calle-Mustienes, et al.
Molecular Cancer Therapeutics|July 24, 2023
First-in-human Study of AZD5153, A Small-molecule Inhibitor of Bromodomain Protein 4, in Patients with Relapsed/Refractory Malignant Solid Tumors and LymphomaErika P Hamilton, Judy S Wang, Amit M Oza, et al.
Nature Reviews. Cancer|March 25, 2016
The importance of p53 pathway genetics in inherited and somatic cancer genomesGiovanni Stracquadanio, Xuting Wang, Marsha D Wallace, et al.
Cancer Research|February 9, 2021
Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug ResponsePing Zhang, Isaac Kitchen-Smith, Lingyun Xiong, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cold Spring Harbor Perspectives in Biology|May 11, 2010
Single-nucleotide polymorphisms in the p53 signaling pathwayLukasz F Grochola, Jorge Zeron-Medina, Sophie Mériaux, et al.
Seminars in Oncology|November 29, 2015
The Personalization of Therapy: Molecular Profiling Technologies and Their ApplicationJorge Zeron-Medina, Maria Ochoa de Olza, Irene Braña, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 6, 2009
Acute abdominal pain in patients with systemic lupus erythematosusOmar Vergara-Fernandez, Jorge Zeron-Medina, Carlos Mendez-Probst, et al.
Pancreas|July 12, 2017
Overexpression of Yes Associated Protein 1, an Independent Prognostic Marker in Patients With Pancreatic Ductal Adenocarcinoma, Correlated With Liver Metastasis and Poor PrognosisMaria Teresa Salcedo Allende, Jorge Zeron-Medina, Javier Hernandez, et al.
Journal of the National Cancer Institute|March 13, 2018
Activity of HSP90 Inhibiton in a Metastatic Lung Cancer Patient With a Germline BRCA1 MutationSusana Cedrés, Enriqueta Felip, Cristina Cruz, et al.
Cell|October 15, 2013
A polymorphic p53 response element in KIT ligand influences cancer risk and has undergone natural selectionJorge Zeron-Medina, Xuting Wang, Emmanouela Repapi, et al.
Cell Reports|August 19, 2014
A polymorphic enhancer near GREM1 influences bowel cancer risk through differential CDX2 and TCF7L2 bindingAnnabelle Lewis, Luke Freeman-Mills, Elisa de la Calle-Mustienes, et al.
Molecular Cancer Therapeutics|July 24, 2023
First-in-human Study of AZD5153, A Small-molecule Inhibitor of Bromodomain Protein 4, in Patients with Relapsed/Refractory Malignant Solid Tumors and LymphomaErika P Hamilton, Judy S Wang, Amit M Oza, et al.
Nature Reviews. Cancer|March 25, 2016
The importance of p53 pathway genetics in inherited and somatic cancer genomesGiovanni Stracquadanio, Xuting Wang, Marsha D Wallace, et al.
Cancer Research|February 9, 2021
Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug ResponsePing Zhang, Isaac Kitchen-Smith, Lingyun Xiong, et al.
Pageof 1